Research & Innovation

At RAMJA Genosensor, our research is rooted in a personal mission to save lives through faster, more accurate infection detection. Backed by years of scientific development and clinical validation, we’ve built India’s first paper-based electrochemical DNA biosensor for detecting infections and antimicrobial resistance (AMR) in just 90 minutes—a breakthrough that is reshaping diagnostic timelines across critical care.

Core Research Areas

Paper-Based Genosensor Technology

Ramja Genosensor developing our own paper based genosensor technology.

Infection and Antimicrobial Resistance (AMR) Detection

We ensure early, precise infection detection in 90 minutes, covering sepsis, UTIs, respiratory, fungal, typhoid, HAI, meningitis, and GI infections.

Nanoparticle-Based Infection Prevention

RAMJA Genosensor’s nanoparticle solution kills germs in 10 minutes, protects for 96 hours, and revolutionizes infection prevention globally

Potentiometer Hardware & Software Development

: We have developed inhouse hardware and Software for single and multichannel hardware paired with Android-based software for Cyclic voltammetry

Screen-Printed Electrode (SPE) Technology

We have enhanced technological advancements in the development of screen-printed electrodes .

AI-Powered Diagnostic Algorithms

We are also developing AI-based algorithms specifically for UTI, SEPSIS, AMR, and meningitis to enhance diagnostic accuracy. contact us

R&D Pipeline (Coming Soon)

Kits for meningitis, STDs, malaria, and lymphatic filariasis.

Our Mission

At RAMJA Genosensor, research fuels our drive to develop cutting-edge solu tions that address real-world healthcare challenges. Since our f ounding in 2018, we have prioritized innovation in life sciences, diagnostics, and infection prevention, with a strong commitment to IVD technology, antimicrobial resistance (AMR) detection, and AI-driven diagnostics.